CommunicationHigh-throughput measurements of ciprofloxacin, clomipramine and FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)s with an 8-channel electrical titrator
-
Add time:08/23/2019 Source:sciencedirect.com
High-throughput measurements of ciprofloxacin, clomipramine and fexofenadine hydrochlorides were performed by employing an automatic 8-channel electrical titrator. Silver nitrate (AgNO3) and sodium tetraphenylborate (NaTPB) were used as titrants. When AgNO3 was used for measuring the drugs in pure form, recoveries were 97.6%–102.0% with RSD values ≤1.0%; for measuring them in pharmaceutical formulations, recoveries were 96.6%–99.1% with RSD values ≤1.0%. Batch samples of eight could be measured simultaneously and maximally 30 measurements per minute could be completed. When NaTPB was used for measuring the drugs in pure form, the recoveries were 96.8%–102.6% with RSD values ≤0.8%; for measuring them in pharmaceutical formulations, the recoveries were 97.5%–102.7% with RSD values ≤0.9%. For all analyses, no auxiliary devices or chemicals were needed and there was no requirement for changing or cleaning working electrodes between measurements. The efficiency, accuracy and precision of the proposed method make it an alternative for routine quality control analyses.
We also recommend Trading Suppliers and Manufacturers of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8). Pls Click Website Link as below: cas 138452-21-8 suppliers
Prev:Influence of antidepressant clomipramine hydrochloride drug on human serum albumin: Spectroscopic study
Next:Formulation and evaluation of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) orally disintegrating tablets for pediatric use) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Isolation and structure elucidation of photodegradation products of fexofenadine09/01/2019
- Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)08/31/2019
- Original Articles: InterventionsSafety and tolerability of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8), 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis08/30/2019
- Pharmaceutics, Preformulation and Drug DeliveryPoloxamer/Cyclodextrin/Chitosan-Based Thermoreversible Gel for Intranasal Delivery of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)08/29/2019
- Effect of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) on cedar pollinosis08/28/2019
- Chapter 4 - FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8)08/27/2019
- ORIGINAL ARTICLESpectrofluorimetric determination of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) in pharmaceutical preparation using silver nanoparticles08/26/2019
- Original ArticleDevelopment and validation of RP-HPLC method for simultaneous estimation of Montelukast Sodium and FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) in combined dosage form08/25/2019
- Formulation and evaluation of FEXOFENADINE HYDROCHLORIDE (cas 138452-21-8) orally disintegrating tablets for pediatric use08/24/2019
-
Health and Chemical more >


